Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseases.
Bennett CL, Magagnoli J, Gundabolu K, Georgantopoulos P, Lebby A, Watson G, Knopf K, Martin L, Carson KR, Hrushesky WJ, Nabhan C, Zyszkowski E, Smith EB, Gale RP, Rosen ST. Bennett CL, et al. Among authors: hrushesky wj. PLoS One. 2024 Sep 25;19(9):e0308205. doi: 10.1371/journal.pone.0308205. eCollection 2024. PLoS One. 2024. PMID: 39321181 Free PMC article.
Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions.
Bennett CL, Focosi D, Socal MP, Bian JC, Nabhan C, Hrushesky WJ, Bennett AC, Schoen MW, Berger JR, Armitage JO; Southern Network on Adverse Reactions. Bennett CL, et al. Among authors: hrushesky wj. Lancet Haematol. 2021 Aug;8(8):e593-e604. doi: 10.1016/S2352-3026(21)00167-8. Lancet Haematol. 2021. PMID: 34329579 Review.
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
Bennett CL, Nagai S, Bennett AC, Hoque S, Nabhan C, Schoen MW, Hrushesky WJ, Luminari S, Ray P, Yarnold PR, Witherspoon B, Riente J, Bobolts L, Brusk J, Tombleson R, Knopf K, Fishman M, Yang YT, Carson KR, Djulbegovic B, Restaino J, Armitage JO, Sartor OA. Bennett CL, et al. Among authors: hrushesky wj. Oncologist. 2021 Aug;26(8):e1418-e1426. doi: 10.1002/onco.13713. Epub 2021 Mar 12. Oncologist. 2021. PMID: 33586299 Free PMC article. Review.
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).
Bennett CL, Hoque S, Olivieri N, Taylor MA, Aboulafia D, Lubaczewski C, Bennett AC, Vemula J, Schooley B, Witherspoon BJ, Godwin AC, Ray PS, Yarnold PR, Ausdenmoore HC, Fishman M, Herring G, Ventrone A, Aldaco J, Hrushesky WJ, Restaino J, Thomsen HS, Yarnold PR, Marx R, Migliorati C, Ruggiero S, Nabhan C, Carson KR, McKoy JM, Yang YT, Schoen MW, Knopf K, Martin L, Sartor O, Rosen S, Smith WK. Bennett CL, et al. Among authors: hrushesky wj. EClinicalMedicine. 2020 Dec 23;31:100693. doi: 10.1016/j.eclinm.2020.100693. eCollection 2021 Jan. EClinicalMedicine. 2020. PMID: 33554084 Free PMC article.
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
Bennett CL, Schoen MW, Hoque S, Witherspoon BJ, Aboulafia DM, Hwang CS, Ray P, Yarnold PR, Chen BK, Schooley B, Taylor MA, Wyatt MD, Hrushesky WJ, Yang YT. Bennett CL, et al. Among authors: hrushesky wj. Lancet Oncol. 2020 Dec;21(12):e575-e588. doi: 10.1016/S1470-2045(20)30485-X. Lancet Oncol. 2020. PMID: 33271114 Review.
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
Hoque S, Chen BJ, Schoen MW, Carson KR, Keller J, Witherspoon BJ, Knopf KB, Yang YT, Schooley B, Nabhan C, Sartor O, Yarnold PR, Ray P, Bobolts L, Hrushesky WJ, Dickson M, Bennett CL. Hoque S, et al. Among authors: hrushesky wj. PLoS One. 2020 Jun 25;15(6):e0234541. doi: 10.1371/journal.pone.0234541. eCollection 2020. PLoS One. 2020. PMID: 32584835 Free PMC article.
End of an era for erythropoiesis-stimulating agents in oncology.
Schoen MW, Hoque S, Witherspoon BJ, Schooley B, Sartor O, Yang YT, Yarnold PR, Knopf KB, Hrushesky WJM, Dickson M, Chen BJ, Nabhan C, Bennett CL. Schoen MW, et al. Among authors: hrushesky wjm. Int J Cancer. 2020 May 15;146(10):2829-2835. doi: 10.1002/ijc.32917. Epub 2020 Feb 28. Int J Cancer. 2020. PMID: 32037527
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.
Bennett CL, Schooley B, Taylor MA, Witherspoon BJ, Godwin A, Vemula J, Ausdenmoore HC, Sartor O, Yang YT, Armitage JO, Hrushesky WJ, Restaino J, Thomsen HS, Yarnold PR, Young T, Knopf KB, Chen B. Bennett CL, et al. Among authors: hrushesky wj. PLoS One. 2019 Jul 31;14(7):e0219521. doi: 10.1371/journal.pone.0219521. eCollection 2019. PLoS One. 2019. PMID: 31365527 Free PMC article.
191 results